Literature DB >> 15984895

Behavioural manifestations of anabolic steroid use.

Adam J Trenton1, Glenn W Currier.   

Abstract

The use of anabolic androgenic steroids (AAS) for gains in strength and muscle mass is relatively common among certain subpopulations, including athletes, bodybuilders, adolescents and young adults. Adverse physical effects associated with steroid abuse are well documented, but more recently, increased attention has been given to the adverse psychiatric effects of these compounds. Steroids may be used in oral, 17alpha-alkylated, or intramuscular, 17beta-esterified, preparations. Commonly, steroid users employ these agents at levels 10- to 100-fold in excess of therapeutic doses and use multiple steroids simultaneously, a practice known as 'stacking'. Significant psychiatric symptoms including aggression and violence, mania, and less frequently psychosis and suicide have been associated with steroid abuse. Long-term steroid abusers may develop symptoms of dependence and withdrawal on discontinuation of AAS. Treatment of AAS abusers should address both acute physical and behavioural symptoms as well as long-term abstinence and recovery. To date, limited information is available regarding specific pharmacological treatments for individuals recovering from steroid abuse. This paper reviews the published literature concerning the recognition and treatment of behavioural manifestations of AAS abuse.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15984895     DOI: 10.2165/00023210-200519070-00002

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  82 in total

1.  Anabolic androgenic steroids and suicide.

Authors:  K J Brower; F C Blow; G A Eliopulos; T P Beresford
Journal:  Am J Psychiatry       Date:  1989-08       Impact factor: 18.112

2.  Anabolic steroid dependence with opioid-type features.

Authors:  F Tennant; D L Black; R O Voy
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

3.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

4.  An acute myocardial infarction occurring in an anabolic steroid user.

Authors:  M J Huie
Journal:  Med Sci Sports Exerc       Date:  1994-04       Impact factor: 5.411

5.  Anorexia nervosa and "reverse anorexia" among 108 male bodybuilders.

Authors:  H G Pope; D L Katz; J I Hudson
Journal:  Compr Psychiatry       Date:  1993 Nov-Dec       Impact factor: 3.735

6.  Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report.

Authors:  N P Boyadjiev; K N Georgieva; R I Massaldjieva; S I Gueorguiev
Journal:  J Sports Med Phys Fitness       Date:  2000-09       Impact factor: 1.637

Review 7.  The cardiac toxicity of anabolic steroids.

Authors:  M L Sullivan; C M Martinez; P Gennis; E J Gallagher
Journal:  Prog Cardiovasc Dis       Date:  1998 Jul-Aug       Impact factor: 8.194

8.  Anabolic steroids and acute schizophrenic episode.

Authors:  W J Annitto; W A Layman
Journal:  J Clin Psychiatry       Date:  1980-04       Impact factor: 4.384

9.  Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids.

Authors:  R D Dickerman; F Schaller; I Prather; W J McConathy
Journal:  Cardiology       Date:  1995       Impact factor: 1.869

10.  Response of serum hormones to androgen administration in power athletes.

Authors:  M Alén; M Reinilä; R Vihko
Journal:  Med Sci Sports Exerc       Date:  1985-06       Impact factor: 5.411

View more
  31 in total

1.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

Review 2.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

Review 3.  Do anabolic-androgenic steroids have performance-enhancing effects in female athletes?

Authors:  Grace Huang; Shehzad Basaria
Journal:  Mol Cell Endocrinol       Date:  2017-07-12       Impact factor: 4.102

4.  Reduced CAG repeats length in androgen receptor gene is associated with violent criminal behavior.

Authors:  Singh Rajender; Guguluth Pandu; J D Sharma; K P C Gandhi; Lalji Singh; Kumarasamy Thangaraj
Journal:  Int J Legal Med       Date:  2008-03-26       Impact factor: 2.686

5.  Development and validation of the appearance and performance enhancing drug use schedule.

Authors:  Tom Hildebrandt; James W Langenbucher; Justine Karmin Lai; Katharine L Loeb; Eric Hollander
Journal:  Addict Behav       Date:  2011-05-11       Impact factor: 3.913

6.  The influence of age of onset and acute anabolic steroid exposure on cognitive performance, impulsivity, and aggression in men.

Authors:  Tom Hildebrandt; James W Langenbucher; Adrianne Flores; Seth Harty; Heather A Berlin; Heather Berlin
Journal:  Psychol Addict Behav       Date:  2014-05-19

7.  Homicidality and Psychosis Caused by an Over-the-Counter Performance-Enhancing Supplement Containing Dendrobium Extract and L-Dopa.

Authors:  Alexandra Flynn; Jana Lincoln; Michael Burke
Journal:  P T       Date:  2016-06

8.  Chronic exposure to anabolic androgenic steroids alters activity and synaptic function in neuroendocrine control regions of the female mouse.

Authors:  Carlos A A Penatti; Joseph G Oberlander; Matthew C Davis; Donna M Porter; Leslie P Henderson
Journal:  Neuropharmacology       Date:  2011-05-27       Impact factor: 5.250

9.  Corticotropin-releasing factor modulation of forebrain GABAergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the female mouse.

Authors:  Joseph G Oberlander; Leslie P Henderson
Journal:  Neuropsychopharmacology       Date:  2012-02-01       Impact factor: 7.853

Review 10.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.